GO
Loading...

Ariad Pharmaceuticals CEO Talks Earnings

Wednesday, 27 Feb 2013 | 6:15 PM ET

Aria uses structure-based drug design to identify molecules able to overcome resistance in therapy. Dr. Harvey Berger, Aria Pharmaceuticals chairman & CEO, offers insight on earnings.